Private Market View

Ajax Therapeutics

Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
$192.5M
Total raised
$143.0M
Last round
Later Stage VC (Series C)
May 2024
How much has Ajax Therapeutics raised?
$143.0Macross 3 recorded rounds · Jun 2019May 2024

Most recently, Ajax Therapeutics raised $95.0M in its Later Stage VC (Series C) (May 2024).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 11 names
  • ·Watchlist + deal alerts for Ajax Therapeutics
Create free account
No card required

Round by round

3 rounds
May 2024Later Stage VC (Series C)$95.0M
+ 1 more investors · free account
May 2021Early Stage VC$37.4MSEC filing
14 investors participated
Jun 2019Early Stage VC$8.0MSEC filing
6 investors participated
For fundraisers
Raising for a company like Ajax Therapeutics?

11 investors have backed Ajax Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 11 investors →

Frequently asked

How much has Ajax Therapeutics raised?
Ajax Therapeutics has raised $143.0M in total across 3 recorded funding rounds.
When was Ajax Therapeutics's last funding round?
Ajax Therapeutics's most recent recorded round was Later Stage VC (Series C) in May 2024, raising $95.0M.